NCT03829475: ICON-2: FMT and Bezlotoxumab Compared to FMT and Placebo for Patients With IBD and CDI
- State
- Completed
- Phase
- Phase 2
- People
- 61 taking part
- Started
- 1 Jan 2020
- Primary completion
- 3 Aug 2023
- Arms
- FMT + Bezlo
- Results
- Posted on the registry
- 4 Feb 2019: Trial registered
- 1 Jan 2020: Trial started
- 11 Dec 2024: Trial results posted
- 1 Jun 2025: Trial completed